Pfizer Seeks Green Light for Covid-19 Vaccine for Young Children
Listen now
Description
P.M. Edition for Oct. 7. Pfizer and its partner BioNTech are seeking authorization from federal health officials for their Covid-19 vaccine for children ages 5 to 11. That means a vaccine for that age group could be available within weeks. For some parents, that is welcome news. But others have some concerns. Health business editor Jonathan Rockoff joins host Annmarie Fertoli to discuss. Learn more about your ad choices. Visit megaphone.fm/adchoices
More Episodes
A.M. Edition for April 16. China is reporting 5.3% GDP growth for the first quarter as efforts to boost the country’s factories begin to show results. However, ifo Institute economist Andreas Baur and WSJ reporter Jason Douglas explain that foreign businesses’ moves to diversify their supply...
Published 04/16/24
P.M. Edition for April 15. Interest-rate cuts could be further down the line than many investors had hoped. Markets reporter Hardika Singh explains what keeping rates higher for longer could mean for the stock market. And Tesla plans to cut more than 10% of its workforce. Autos reporter Ryan...
Published 04/15/24
Published 04/15/24